Zenas BioPharma Inc.
ZBIO | NASDAQ
$25.93
-$2.53 (-8.89%)
At close: Nov 5, 2026, 4:00 PM ET
$24.56
-$1.37 (-5.28%)
After-hours:
Nov 5, 2026, 6:19 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
Revenue | 10M | 5M | 50M | n/a |
Cost of Revenue | n/a | 139.14M | n/a | 61.69M |
Gross Profit | 10M | -134.14M | 50M | -61.69M |
Operating Income | -211.39M | -163.89M | -37.15M | -76.2M |
Interest Income | 12.15M | n/a | n/a | n/a |
Pretax Income | -377.82M | -156.56M | -36.82M | -119.28M |
Net Income | -377.74M | -156.99M | -37.12M | -119.28M |
Selling & General & Admin | 53.32M | 29.75M | 17.11M | 13.51M |
Research & Development | 168.06M | 139.14M | 60.03M | 62.69M |
Other Expenses | n/a | -139.14M | 10M | -61.69M |
Operating Expenses | 221.39M | 29.75M | 87.15M | 14.51M |
Interest Expense | 7.33M | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | 900K | n/a | 700K |
Cost & Expenses | 221.39M | 168.89M | 87.15M | 76.2M |
Income Tax Expense | -79K | 429K | 301K | n/a |
Shares Outstanding (Basic) | 44.73M | 41.79M | 38.32M | 38.32M |
Shares Outstanding (Diluted) | 44.73M | 41.79M | 38.32M | 38.32M |
EPS (Basic) | -8.44 | -3.76 | -0.97 | -3.11 |
EPS (Diluted) | -8.44 | -3.76 | -0.97 | -3.11 |
EBITDA | -370.43M | -156.42M | -27.03M | -75.12M |
EBIT | -370.49M | -156.56M | -27.15M | -75.2M |
Depreciation & Amortization | 56K | 137K | 113K | 78K |
Add to Watchlist
Select watchlists to add or remove ZBIO